NEW You can now listen to Fox News articles!
The Centers for Disease Control and Prevention (CDC) warns of the potential for “rebound of COVID-19” after patients take the oral antiviral drug called Paxlovid. Treatment is permitted under emergency use by the Food and Drug Administration for adult and pediatric patients with mild to moderate COVID-19 who are at risk for serious illness.
“If you take Paxlovid, you may have symptoms again,” said CDC director Dr. Rochelle Walensky. “We haven’t seen anyone come back with symptoms that need to go to the hospital. So, in general, a smoother course.”
COVID-19 rebound is a return of COVID-19 symptoms or a new positive (after negative) viral test two to eight days after improvement.
Microscopic view of the virus. (iStock)
But the agency noted that some people may experience a brief rise in symptoms as part of the natural course of the disease and “regardless of treatment with Paxlovid and regardless of vaccination status,” according to a recent Health Counseling. CDC health alert network.
THE DOJ REQUESTS THE COURT TO INVEST THE REQUIREMENT OF LIFTING THE STANDARD FOR MASKS COVID IN PUBLIC TRANSPORT
The agency continues to recommend antiviral treatment, as Paxlovid helps prevent hospitalization and death from COVID-19. It should be taken within five days of the onset of symptoms.
“Both the recurrence of the disease and the positive results of the tests improved or resolved (median of 3 days) without additional treatment against COVID-19. According to the information in the case reports, the rebound of COVID-19 “It did not represent a SARS-CoV-2 reinfection or the development of Paxlovid resistance, and no other respiratory pathogens were identified among the known cases,” the CDC said.
The Centers for Disease Control and Prevention (CDC) has been widely criticized and ridiculed after a series of confusing messages baffled Americans amid a record increase in COVID-19 cases and propagation of the omicron variant. (iStock)
It is possible to transmit the infection while experiencing the COVID-19 rebound, but at this time it is unknown how the likelihood of transmission during the rebound compares with the probability of transmission during the initial infection.
MEMBERS OF THE AIR FORCE DENIED RELIGIOUS EXEMPTIONS IN THE COVID VACCINE FILE TO STOP PUNISHMENTS, TERMINATIONS
The agency added that there is no evidence that Paxlovid needs to be expanded or that other antiviral therapies are needed to recover COVID-19, but the risk of transmission during this period can be managed according to CDC guidelines. about insulation.
For those experiencing a bounce of COVID-19, Walensky advised, “They should do the test. They should put the mask back on. And if their test is positive, restart the isolation protocol.”
CLICK HERE TO GET THE FOX NEWS APP